Zapała, Ł.; Kunc, M.; Sharma, S.; Biernat, W.; Radziszewski, P.
Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics 2021, 11, 2159.
https://doi.org/10.3390/diagnostics11112159
AMA Style
Zapała Ł, Kunc M, Sharma S, Biernat W, Radziszewski P.
Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics. 2021; 11(11):2159.
https://doi.org/10.3390/diagnostics11112159
Chicago/Turabian Style
Zapała, Łukasz, Michał Kunc, Sumit Sharma, Wojciech Biernat, and Piotr Radziszewski.
2021. "Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus" Diagnostics 11, no. 11: 2159.
https://doi.org/10.3390/diagnostics11112159
APA Style
Zapała, Ł., Kunc, M., Sharma, S., Biernat, W., & Radziszewski, P.
(2021). Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics, 11(11), 2159.
https://doi.org/10.3390/diagnostics11112159